Treatment of pregnancy-associated breast cancer

Bibliography

• Bonnier P, Romain S, Dilhuydy JM, et al. Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer 1997;72:720-7
   PubMedGoogle Scholar
• Ishida T, Yokoe T, Kasumi F, et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res 1992;83:1143-9
   PubMedGoogle Scholar
• Liberman L, Giess CS, Dershaw DD, et al. Imaging of pregnancy-associated breast cancer. Radiology 1994;191:245-8
   PubMedGoogle Scholar
• Tretli S, Kvalheim G, Thoresen S, Host H. Survival of breast cancer patients diagnosed during pregnancy or lactation. Br J Cancer 1988;58:382-4
   PubMedGoogle Scholar
• Abstracts of the 24th Annual Meeting of the German Society of Senology. 2-4 September 2004, Freiburg, Germany. Onkologie 2004;27(Suppl 2):1-65
   Google Scholar
• Thurlimann B, Muller A, Senn HJ. Management of primary breast cancer: an update. Onkologie 2004;27:175-9
   PubMedGoogle Scholar
• Harbeck N. Adjuvant chemotherapy in primary breast cancer. Onkologie 2003;26(Suppl 7):17-20
   PubMedGoogle Scholar
• Janicke F. Perspectives in oncology. Onkologie 2003;26(Suppl 7):3
   PubMedGoogle Scholar
• Abstracts of the 23rd Annual Meeting of the German Society of Senology. 19-21 June 2003, Munich, Germany. Onkologie 2003;26(Suppl 2):1-100
   Google Scholar
• Petrek J, Seltzer V. Breast cancer in pregnant and postpartum women. J Obstet Gynaecol Can 2003;25:944-50
   PubMedGoogle Scholar
• Antonelli NM, Dotters DJ, Katz VL, Kuller JA. Cancer in pregnancy: a review of the literature. Obstet Gynecol Surv 1996;51:125-34
   PubMedGoogle Scholar
• Woo JC, Yu T, Hurd TC. Breast cancer in pregnancy: a literature review. Arch Surg 2003;138:91-8
   PubMedGoogle Scholar
• Barnes DM, Newman LA. Pregnancy-associated breast cancer: a literature review. Surg Clin North Am 2007;87:417-30, x
   PubMedGoogle Scholar
• Nugent P, O'Connell TX. Breast cancer and pregnancy. Arch Surg 1985;120:1221-4
   PubMedGoogle Scholar
• Theriault R, Hahn K. Management of breast cancer in pregnancy. Curr Oncol Rep 2007;9:17-21
   PubMedGoogle Scholar
• Mathelin C, Annane K, Treisser A, et al. Pregnancy and post-partum breast cancer: a prospective study. Anticancer Res 2008;28:2447-52
   PubMedGoogle Scholar
• Available from: http://www.germanbreastgroup.de.2008
   Google Scholar
• Nicklas AH, Baker ME. Imaging strategies in the pregnant cancer patient. Semin Oncol 2000;27:623-32
   PubMedGoogle Scholar
• Yang WT, Dryden MJ, Gwyn K, et al. Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy. Radiology 2006;239:52-60
   PubMed Web of Science ®Google Scholar
• Loibl S, von Minckwitz G, Gwyn K, et al. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 2006;106:237-46
   PubMed Web of Science ®Google Scholar
• Gerber B, Seitz E, Muller H, et al. Perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread. Breast Cancer Res Treat 2003;82:29-37
   PubMed Web of Science ®Google Scholar
• Poniecka AW, Krasuski P, Gal E, et al. Granulomatous inflammation of the breast in a pregnant woman: report of a case with fine needle aspiration diagnosis. Acta Cytol 2001;45:797-801
   PubMedGoogle Scholar
• Shannon J, Douglas-Jones AG, Dallimore NS. Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results? J Clin Pathol 2001;54:762-5
   PubMedGoogle Scholar
• Westenend PJ, Sever AR, Beekman-De Volder HJ, Liem SJ. A comparison of aspiration cytology and core needle biopsy in the evaluation of breast lesions. Cancer 2001;93:146-50
   PubMedGoogle Scholar
• Petrek JA, Dukoff R, Rogatko A. Prognosis of pregnancy-associated breast cancer. Cancer 1991;67:869-72
   PubMed Web of Science ®Google Scholar
• Berry DL, Theriault RL, Holmes FA, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999;17:855-61
   PubMed Web of Science ®Google Scholar
• Max MH, Klamer TW. Pregnancy and breast cancer. South Med J 1983;76:1088-90
   PubMed Web of Science ®Google Scholar
• Mitre BK, Kanbour AI, Mauser N. Fine needle aspiration biopsy of breast carcinoma in pregnancy and lactation. Acta Cytol 1997;41:1121-30
   PubMed Web of Science ®Google Scholar
• Giacalone PL, Laffargue F, Benos P. Chemotherapy for breast carcinoma during pregnancy: a French national survey. Cancer 1999;86:2266-72
   PubMed Web of Science ®Google Scholar
• Elledge RM, Ciocca DR, Langone G, McGuire WL. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients. Cancer 1993;71:2499-506
   PubMed Web of Science ®Google Scholar
• Holdaway IM, Mason BH, Kay RG. Steroid hormone receptors in breast tumours presenting during pregnancy or lactation. J Surg Oncol 1984;25:38-41
   PubMedGoogle Scholar
• Tworoger SS, Hankinson SE. Prolactin and breast cancer risk. Cancer Lett 2006;243:160-9
   PubMed Web of Science ®Google Scholar
• Pujol P, Daures JP, Thezenas S, et al. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause. Cancer 1998;83:698-705
   PubMed Web of Science ®Google Scholar
• Gwyn K, Theriault R. Breast cancer during pregnancy. Oncology (Huntingt) 2001;15:39-46
   PubMedGoogle Scholar
• Kuerer HM, Cunningham JD, Brower ST, Tartter PI. Breast carcinoma associated with pregnancy and lactation. Surg Oncol 1997;6:93-8
   PubMedGoogle Scholar
• Annane K, Bellocq JP, Brettes JP, Mathelin C. Infiltrative breast cancer during pregnancy and conservative surgery. Fetal Diagn Ther 2005;20:442-4
   PubMedGoogle Scholar
• Guinee VF, Olsson H, Moller T, et al. Effect of pregnancy on prognosis for young women with breast cancer. Lancet 1994;343:1587-9
   PubMed Web of Science ®Google Scholar
• Gentilini O, Cremonesi M, Trifiro G, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004;15:1348-51
   PubMed Web of Science ®Google Scholar
• Keleher A, Wendt R III, Delpassand E, et al. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J 2004;10:492-5
   PubMedGoogle Scholar
• Crivellaro M, Senna G, Dama A, et al. Anaphylaxis due to patent blue dye during lymphography, with negative skin prick test. J Investig Allergol Clin Immunol 2003;13:71-2
   PubMedGoogle Scholar
• Greskovich JF Jr, Macklis RM. Radiation therapy in pregnancy: risk calculation and risk minimization. Semin Oncol 2000;27:633-45
   PubMedGoogle Scholar
• Ebert U, Loffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol Ther 1997;74:207-20
   PubMed Web of Science ®Google Scholar
• Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004;5:283-91
   PubMed Web of Science ®Google Scholar
• Caligiuri MA, Mayer RJ. Pregnancy and leukemia. Semin Oncol 1989;16:388-96
   PubMed Web of Science ®Google Scholar
• Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol 1989;16:337-46
   PubMed Web of Science ®Google Scholar
• Zemlickis D, Lishner M, Degendorfer P, et al. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 1992;152:573-6
   PubMed Web of Science ®Google Scholar
• Zemlickis D, Lishner M, Degendorfer P, et al. Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol 1992;166:781-7
   PubMedGoogle Scholar
• Williams SF, Bitran JD. Cancer and pregnancy. Clin Perinatol 1985;12:609-23
   PubMedGoogle Scholar
• Aviles A, Niz J. Long-term follow-up of children born to mothers with acute leukemia during pregnancy. Med Pediatr Oncol 1988;16:3-6
   PubMedGoogle Scholar
• Ebert U, Loffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol Ther 1997;74:207-20
   PubMed Web of Science ®Google Scholar
• Karp GI, Von Oeyen P, Valone F, et al. Doxorubicin in pregnancy: possible transplacental passage. Cancer Treat Rep 1983;67:773-7
   PubMedGoogle Scholar
• Murray CL, Reichert JA, Anderson J, Twiggs LB. Multimodal cancer therapy for breast cancer in the first trimester of pregnancy. A case report. JAMA 1984;252:2607-8
   PubMed Web of Science ®Google Scholar
• Toledo TM, Harper RC, Moser RH. Fetal effects during cyclophosphamide and irradiation therapy. Ann Intern Med 1971;74:87-91
   PubMed Web of Science ®Google Scholar
• Turchi JJ, Villasis C. Anthracyclines in the treatment of malignancy in pregnancy. Cancer 1988;61:435-40
   PubMed Web of Science ®Google Scholar
• Giacalone PL, Laffargue F, Benos P. Chemotherapy for breast carcinoma during pregnancy: a French national survey. Cancer 1999;86:2266-72
   PubMed Web of Science ®Google Scholar
• Peres RM, Sanseverino MT, Guimaraes JL, et al. Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: a multicenter study. Braz J Med Biol Res 2001;34:1551-9
   PubMed Web of Science ®Google Scholar
• Meyer-Wittkopf M, Barth H, Emons G, Schmidt S. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet Gynecol 2001;18:62-6
   PubMed Web of Science ®Google Scholar
• Reynoso EE, Keating A, Baker MA. Acute leukemia occurring 19 years after treatment of acute lymphoblastic leukemia. Cancer 1987;59:1963-5
   PubMed Web of Science ®Google Scholar
• Cantini E, Yanes B. Acute myelogenous leukemia in pregnancy. South Med J 1984;77:1050-2
   PubMed Web of Science ®Google Scholar
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-717
   PubMed Web of Science ®Google Scholar
• von Minckwitz G. Taxanes in primary systemic treatment of breast cancer. Onkologie 2003;26(Suppl 7):21-5
   PubMedGoogle Scholar
• De Santis M, Lucchese A, De Carolis S, et al. Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. Eur J Cancer Care (Engl) 2000;9:235-7
   PubMedGoogle Scholar
• Gonzalez-Angulo AM, Walters RS, Carpenter RJ Jr, et al. Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin Breast Cancer 2004;5:317-19
   PubMedGoogle Scholar
• Gadducci A, Cosio S, Fanucchi A. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res 2003;23:5225-9
   PubMed Web of Science ®Google Scholar
• Bader AA, Schlembach D, Tamussino KF. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol 2007;8:79-81
   PubMed Web of Science ®Google Scholar
• Lycette JL, Dul CL, Munar M. Effect of pregnancy on the pharmacokinetics of paclitaxel: a case report. Clin Breast Cancer 2006;7:342-4
   PubMedGoogle Scholar
• Gainford MC, Clemons M. Breast cancer in pregnancy: are taxanes safe? Clin Oncol 2006;18:159
   Google Scholar
• Potluri V, Lewis D, Burton GV. Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature. Clin Breast Cancer 2006;7:167-70
   PubMedGoogle Scholar
• Nieto Y, Santisteban M, Aramendia JM. Docetaxel administered during pregnancy for inflammatory breast carcinoma. Clin Breast Cancer 2006;6:533-4
   PubMedGoogle Scholar
• Sekar R, Stone PR. Trastuzumab use for breast cancer in pregnancy. Obstet Gynecol 2007;110:507-10
   PubMed Web of Science ®Google Scholar
• Reynoso EE, Shepherd FA, Messner HA, et al. Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol 1987;5:1098-106
   PubMed Web of Science ®Google Scholar
• Williams SF, Schilsky RL. Antineoplastic drugs administered during pregnancy. Semin Oncol 2000;27:618-22
   PubMed Web of Science ®Google Scholar
• Gralla RJ, Osoba D, Kris MG, et al. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American society of clinical oncology. J Clin Oncol 1999;17:2971-94
   PubMed Web of Science ®Google Scholar
• Cullins SL, Pridjian G, Sutherland CM. Goldenhar's syndrome associated with tamoxifen given to the mother during gestation. JAMA 1994;271:1905-6
   PubMedGoogle Scholar
• Isaacs RJ, Hunter W, Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy–case report and literature review. Gynecol Oncol 2001;80:405-8
   PubMed Web of Science ®Google Scholar
• Clark RM, Reid J. Carcinoma of the breast in pregnancy and lactation. Int J Radiat Oncol Biol Phys 1978;4:693-8
   PubMedGoogle Scholar
• Witzel ID, Muller V, Harps E, et al. Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol 2008;19:191-2
   PubMed Web of Science ®Google Scholar
• Shrim A, Garcia-Bournissen F, Maxwell C, et al. Trastuzumab treatment for breast cancer during pregnancy. Can Fam Physician 2008;54:31-2
   PubMedGoogle Scholar
• Averette HE, Mirhashemi R, Moffat FL. Pregnancy after breast carcinoma: the ultimate medical challenge. Cancer 1999;85:2301-4
   PubMedGoogle Scholar
• Lee SJ, Schover LR, Partridge AH, et al. American society of clinical oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24:2917-31
   PubMed Web of Science ®Google Scholar
• Velentgas P, Daling JR, Malone KE, et al. Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer 1999;85:2424-32
   PubMed Web of Science ®Google Scholar
• Sankila R, Heinavaara S, Hakulinen T. Survival of breast cancer patients after subsequent term pregnancy: ‘healthy mother effect’. Am J Obstet Gynecol 1994;170:818-23
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z. GnRH-agonists in fertility preservation. Curr Opin Endocrinol Diabetes Obes 2008;15:523-8
   PubMedGoogle Scholar
• Gerber B, Stehle H, Ricardo F, et al. A prospective randomized multicenter study to prevent chemotherapy-induced ovarian failure with the GnRH-agonist goserelin in young hormone-insensitive breast cancer patients receiving anthracycline containing (neo-) adjuvant chemotherapy (GBG 37). [abstract 526]. 2009 ASCO Annual Meeting 9 A.D
   Google Scholar
• Falcone T, Bedaiwy MA. Fertility preservation and pregnancy outcome after malignancy. Curr Opin Obstet Gynecol 2005;17:21-6
   PubMed Web of Science ®Google Scholar
• Bukovic D, Fajdic J, Hrgovic Z, et al. Sexual dysfunction in breast cancer survivors. Onkologie 2005;28:29-34
   PubMedGoogle Scholar
• Lamont RF. Evidence-based labour ward guidelines for the diagnosis, management and treatment of spontaneous preterm labour. J Obstet Gynaecol 2003;23:469-78
   PubMedGoogle Scholar
• Mir O, Berveiller P, Rouzier R, et al. Chemotherapy for breast cancer during pregnancy: is epirubicin safe? Ann Oncol 2008;10:1814-15
   Google Scholar
• Middleton LP, Amin M, Gwyn K, et al. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer 2003;98:1055-60
   PubMed Web of Science ®Google Scholar
• Levine MN, Bramwell VH, Pritchard KL, et al. Randomized trial of intensive cyclophosphamide, epirubicin and fluorouracil chemotherapy compared with cyclophosphamide, methothrexat and fluorouracil in premenopausal women with node-positive breast cancer. J Clin Oncol 1998;16:2651-8
   PubMed Web of Science ®Google Scholar
• Bonneterre J, Roche H, Kerbrat P, et al. French Adjuvant Study Group 05 trial (FEC 50 vs FEC 100): 10-year update of benefit/risk ratio after adjuvant chemotherapy (CT) in node-positive (N+), early breast cancer (EBC) patients (pts) [abstract]. Proc ASCO 2003;22:24
   Google Scholar
• Smalley RV, Lefante J, Bartolucci A, et al. A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer. Breast Cancer Res Treat 1983;3:209-20
   PubMed Web of Science ®Google Scholar
• Roche H, Fumoleau P, Spielmann M, et al. Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial. J Clin Oncol 2006;24:5664-71
   PubMed Web of Science ®Google Scholar